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Background: Patients with severe asthma experience problems in different areas of their
health status. Identification of these areas will provide insight in the patients needs and
perhaps what determines the burden of disease. The Nijmegen Clinical Screening Instrument
(NCSI) was recently developed for use in clinical practice in patients with COPD and provides
a detailed picture of the patients’ physiological functioning, symptoms, functional impair-
ment, and Quality of Life. Main purpose of this study is to evaluate the use of the NCSI as
compared to the Asthma Control Questionnaire (ACQ) and Asthma Quality of Life Questionnaire
(AQLQ) in patients with severe asthma.
Methods: The NCSI, AQLQ, and ACQ were measured in 167 patients with severe asthma. Pear-
son correlations were calculated between NCSI sub-domains and the AQLQ domains and the
ACQ.
Results: The NCSI measures more aspects of health status as compared to the ACQ and AQLQ in
patients with severe asthma. Beside symptoms, subjective impairment, and emotions the NCSI
also measures general Quality of Life, health related Quality of Life, satisfaction with rela-
tions, fatigue, and behavioural impairment. On all NCSI sub-domains proportions of patients
with normal, mild, and severe problems were found. Heterogeneity was found on the numberof Medical Psychology and Department of Pulmonary Diseases, Radboud University Nijmegen Medical
k, The Netherlands. Tel.: þ31 24 6859557; fax: þ31 24 6859531.
Peters@radboudumc.nl (J.B. Peters).
to this work.
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Health status in severe asthma 279and on the combination of sub-domains on which patients reported severe problems.
Conclusions: The NCSI provides a more detailed picture of the individual patient with severe
asthma than the ACQ and AQLQ. The use of the NCSI might allow quick identification of the
problem areas and possible factors that impair health status.
ª 2013 Elsevier Ltd. All rights reserved.Introduction
Patients with severe asthma suffer from serious problems in
health status, such as symptoms during day- and nighttime
[1], impairments in daily life activities [2], and lower
Quality of Life (QoL) [3e6]. For adequate assessment and
management of patients with severe asthma a detailed
evaluation of patients’ needs would be helpful to identify
the factors that influence their health status. An instrument
that provides a detailed picture of the different aspects of
the patient’s health status would be very useful. This in-
formation would guide treatment, help to open up the
communication with the patient, and to improve the pa-
tient’s self-management.
Many disease specific and generic questionnaires exist
that measure aspects of health status. In asthma the
Asthma control Questionnaire (ACQ) and Asthma Quality of
Life Questionnaire (AQLQ) and to a lesser extend the, St
George Respiratory Questionnaire (SGRQ) and Quality of
Life for Respiratory Illness Questionnaire (QoL-RiQ) are
used for this purpose [7e10]. These instruments, especially
the AQLQ and ACQ, are widely used in research, have
proven to be valid, reliable, and are able to measure
change, to describe groups and effects of interventions.
However, on the level of the individual patient and in
clinical care these instruments seem less appropriate. The
ACQ only indicates whether the asthma is controlled or
uncontrolled in a patient and provides no information on
health status. The AQLQ measures only four domains, and
lacks normative data, which means that the clinical rele-
vance of particular scores on the level of the individual
patient is unclear.
The Nijmegen Clinical Screening Instrument (NCSI) was
specifically developed for use in clinical care of patients
with COPD, to detect the problems in health status on in-
dividual patient base. [11] The NCSI measures eleven sub-
domains of health status covering aspects of physiological
functioning, symptoms, functional impairment and Quality
of Life with a battery of subscales from disease specific and
generic questionnaires, as well as the results of lung func-
tion test. For each sub-domain of the NCSI normative data
indicating normal functioning, mild problems and severe
problems were collected. Immediately after the patient
has completed the questionnaire part on the computer, are
the results presented on the graphical PatientProfileChart
(Fig. 1) [11].
Although developed and validated in patients with COPD
[11], have previous studies shown that all NCSI sub-domains
are relevant in other diseases as well, including Q-fever
[12,13], and cardiac diseases (submitted). We hypothesized
that the NCSI can be used also in patients with asthma.
Asthma and COPD have overlapping clinical characteristics
and both patient groups report similar problems in healthstatus. Moreover, patients with severe asthma are known to
experience severe symptoms, functional impairment, and
lower QoL [1e6]. Therefore, a group of patients with severe
asthma would be most suitable to examine whether the
NCSI can identify problems in health status in patients with
severe asthma.
The main purpose of this study is to evaluate the NCSI in
measuring the unmet needs in patients with severe asthma.
The primary aim is to evaluate the internal consistency of
the NCSI, and to investigate the relationships between the
sub-domains of the NCSI, the ACQ total, and the AQLQ
domains in patients with severe asthma. The secondary aim
is to evaluate to what extent the NCSI measures other sub-
domains of health status as compared to the disease spe-
cific AQLQ and ACQ, and whether these sub-domains are
relevant in patients with severe asthma.
Materials and methods
Study design
This cross-sectional study was conducted in patients with
severe asthma who were referred to the Dutch Asthma
Centre in Davos for high altitude treatment. On admission,
all patients were assessed according to a systematic pro-
tocol. The study was approved by the Medical Ethical
Committee of the Amsterdam Medical Centre and the
approval was adopted by the Asthma Centre Davos. Written
informed consent was obtained from all patients partici-
pating in the study. All data was collected in usual care,
shortly after admission, and anonymized before analysis.
Study population
Adult patient (18e75 years) with a diagnosis of severe
asthma who were referred to the Dutch Asthma Centre
Davos, Switzerland, between January 2008 and January
2010 were asked to participate in the study. Severe asthma
was defined according to the international criteria [14].
Dutch lung physicians send patients with severe asthma to
the high altitude clinic in Davos, when optimal treatment,
according to the GINA guidelines at sea level is not enough
to reach control of asthma. [15] All patients were pre-
scribed high doses of inhaled corticosteroids (1000 mg$day
of fluticasone or equivalent) or oral corticosteroids, com-
bined with long-acting bronchodilators for at least 1 year, in
accordance to the GINA Guidelines stages 4e6 [15]. Most
patients also used additional asthma medications (e.g. an-
tihistamines, montelukast, theaphylline etc). Patients with
a smoking history >15 years, had to show reversibility in
FEV1 to short-acting beta agonist >12% predicted in order
to exclude patients with smoking related COPD. All patients
Figure 1 The PatientProfileChart a graphical representation of the patient’s scores on the diverse aspects of health status as
measured by the NCSI. Note: in this figure we plotted the mean score of the study group (blue dots) on that particular aspect
instead of the individual score which is normally plotted in the graphs. The green area represents normal functioning, yellow area
mild problems, and red area severe problems. (For interpretation of the references to colour in this figure legend, the reader is
referred to the web version of this article.)
280 J.B. Peters et al.were symptomatic and had experienced at least one severe
exacerbation during the past year requiring a course of oral
corticosteroids. Before referral to the high altitude clinic,
inhalation technique and adherence with treatment was
checked by the referring pulmonologist.Questionnaires
AQLQ. The Asthma Quality of Life Questionnaire standard-
ized version (AQLQ-S) [1,8] measures four domains: symp-
toms, activity limitation, emotional function, and
Health status in severe asthma 281environmental stimuli. Score range from 1 to 7, lower
scores indicate more problems.
ACQ. The Asthma Control Questionnaire (ACQ) [7,16]
consists of six items which are scored from 0 (totally
controlled) to 6 (severely uncontrolled) covering day and
nighttime symptoms, activity limitations and rescue bron-
chodilator use. The cut-off point for well controlled asthma
is lower than 1.5 [7].
NCSI. The Nijmegen Clinical Screening Instrument (NCSI)
[11] is a battery of existing tests and disease specific and
generic instruments that provide a detailed assessment of
health status. The NCSI covers four main domains: physio-
logical functioning, symptoms, functional impairment, and
Quality of Life. These main domains are subdivided into
elevensub-domains thatmeasure:airflow,bodycomposition,
static lung volumes (excluded in the present study), subjec-
tive symptoms, dyspnoea emotions, fatigue, behavioural
impairment, subjective impairment, general QoL, health
related QoL, and satisfaction relations. See Table 1
[10,17e22] for the definitions of the sub-domains and the
included tests and instruments by which these sub-domains
are measured. Completion of the questionnaire part of the
NCSI is computerized [22] and scoring is automated. Norma-
tive data for each subscalewere collected in healthy subjects
and different samples of patients with COPD to identify cut-
offs scores indicating normal functioning, mild problems or
severe problems [11]. For each patient a personal profile can
be made visible on the PatientProfileChart, see Fig. 1. For all
sub-domains: the higher the score the more problematic.
Measures
Lung function parameters. Forced expiratory volume in
1 s (FEV1) was assessed after maintenance medication andTable 1 Domains, sub-domains, definitions, instruments and n
tionnaire part of the Nijmegen Clinical Screening Instrument (NC
Domain Sub-domain Definition
Physiological
functioning
Airflow
Body composition
Symptoms Subjective
symptoms
The patient’s overall burden
of pulmonary symptoms
Dyspnoea
emotions
The level of frustration and
anxiety a person experiences
when dyspnoeic
Fatigue The level of experienced fatig
Functional
impairment
Behavioural
impairment
The extent to which a person
perform specific and concrete
as a result of having the disea
Subjective
impairment
The experienced degree of
impairment in general
Quality of Life General Quality
of Life
Mood and the satisfaction of
with his/her life as a whole
Health-related
Quality of Life
Satisfaction related to physic
functioning and the future
Satisfaction
relations
Satisfaction with the (absent)
relationships with spouse and
PARS-D: Physical Activity Rating Scale-Dyspnea; DEQ: Dyspnea Emotio
Impact Profile; QoLRiQ: Quality of Life for Respiratory Illness Questioinhalation of 400 mg salbutamol. Exhaled nitric oxide mea-
surements were performed by standardized method [23]
using the NIOX.
Sensitization to specific IgE was assessed with a panel of
common aero-allergens (house dust mite, mixed grass and
birch pollen, cat and dog dander and Aspergillus) by UniCap
and expressed in kU/L. Patients were classified as allergic
sensitized if IgE to one or more allergens was >0.35 kU/L.
Statistics
Data are presented as mean  standard deviation (SD),
unless stated otherwise. Cronbach’s Alpha reliability co-
efficients were calculated to study the internal consistency
reliability of the items of each sub-domain/subscale of the
NCSI, ACQ and AQLQ, an a > 0.70 is considered reliable.
Pearson correlation coefficients were calculated to study
the relationships between the sub-domains of the NCSI, the
ACQ total, and the subscales of the AQLQ. Conceptual
similarity was defined by a correlation of 0.70 or higher. To
avoid Type I error due to multiple testing P was set at 0.01.
All statistics were performed by using SPSS 16.0 (SPSS Inc,
Chicago, IL.).Results
Subject characteristics
One hundred and eighty patients were admitted to the high
altitude clinic between January 2008 and January 2010, of
which 167 agreed to participate in the study. Thirteen pa-
tients were not able to fill the questionnaires adequatelyumber of included items from the instrument of the ques-
SI).
Instruments/measurement No of
items
Post bronchodilator FEV1% predicted
Body Mass Index
PARS-D Global Dyspnea Activity [19] 2
PARS-D Global Dyspnea Burden [19]
DEQ Frustration [19] 6
DEQ Anxiety [19]
ue CIS Subjective fatigue [20] 8
cannot
activities
se
SIP Home Management [21] 22
SIP Ambulation [21]
QoLRiQ General Activities [10] 4
a person BDI Primary Care [16] 12
Satisfaction With Life Scale [18]
al Satisfaction physiological functioning [19] 2
Satisfaction future [19]
others
Satisfaction spouse [19] 2
Satisfaction social [19]
ns Questionnaire; CIS: Checklist Individual Strength; SIP: Sickness
nnaire; BDI, Beck Depression Inventory.
Table 2 Patient characteristics (N Z 167). Data are pre-
sented as N (%), mean  SD or median (range), unless
otherwise stated.
Age (yrs) 44.5  15
Sex (male) N (%) 58 (35%)
Asthma duration (yrs) 30 (1e66)
Sensitized to allergens 112 (67%)
BMI 28.1 (range 16.8e54.5)
Ex-smokers 57 (34%)
FEV1% pred. 87.7  24.5
FeNO ppb 20.7 (4e233)
ACQ score 3.2  1.1
ICS mg/day 0e8000
Daily OCS N (%) 82 (49%)
BMI: body mass index; FEV1: forced expiratory volume in 1 s; %
pred: % predicted; FeNO: exhaled nitric oxide fraction; ACQ:
Asthma Control Questionnaire score, 0-6, where 0 Z well
controlled; ICS: inhalation corticosteroids; OCS: oral cortico-
steroids.
282 J.B. Peters et al.because of illiteracy or did not agree to participate for
personal reasons. The baseline characteristics of the 167
patients with severe asthma included in this study are
presented in Table 2. Uncontrolled asthma was found in 91%
(ACQ >1.5) of the patients in this study.
NCSI-scores in severe asthma patients
Overall, high percentages of severe problems were found in
the sub-domains of symptoms, functional impairment, and
QoL Fig. 2. The most prevalent sub-domains with severe
impairment were subjective symptoms (82.0%), fatigue
(90.4%), subjective impairment (86.8%), and general QoL
(81.4%). Furthermore, 31.7% of the patients had clinically
relevant depressive symptoms (subscale within sub-domain
general QoL, not shown).Figure 2 Percentages of patients with asthma with normal functi
of the NCSI.Diversity between patients was found in the number of
sub-domains with severe problems (Fig. 3). Nineteen
percent of patients were severely impaired in all eight sub-
domains of the NCSI, and 80% of patients had five or more
severely impaired sub-domains.
Intercorrelations of the questionnaires
With respect to the AQLQ, the domain activity reached
conceptual similarity with the domain symptoms and envi-
ronmental stimuli, although the latter two domains were
only moderately related (Table 3).
Correlations between most of the NCSI sub-domains
were moderate to absent, as shown in Table 4. Only the
sub-domains subjective symptoms and subjective impair-
ment reached the criterion for conceptual similarity
(r > 0.70), indicating that these two sub-domains measure
highly related concepts.
Reliability of the questionnaires
For all sub-domains the internal consistency was good,
irrespective of the questionnaire used, except for the NCSI
sub-domains of QoL see Table 5. However, the Cronbach’s
alpha of the two separate subscales that together measure
general QoL was good (Satisfaction With Life Scale (SWLS)
0.88 and Beck’s Depression Inventory (BDI) 0.83),
respectively.
Conceptual similarity between the questionnaires
The ACQ-total score reached conceptual similarity with
AQLQ-symptoms and nearly with AQLQ-activity limitations
(Table 6). The ACQ-total showed conceptual similarity only
with NCSI subjective impairment, and nearly with NCSI
subjective symptoms.
The AQLQ-symptoms showed conceptual similarity with
NCSI subjective impairment, and nearly with NCSI subjectiveoning, mild problems and severe problems for each sub-domain
Figure 3 Distribution of percentages of patients with severe
asthma with severe problems on n number of sub-domains of
the NCSI.
Health status in severe asthma 283symptoms. AQLQ-activity limitations nearly reached con-
ceptual similarity with NCSI subjective impairment. AQLQ-
emotional functioning reached conceptual similarity with
NCSI dyspnoea emotions. AQLQ-environmental stimuli did
not reach conceptual similarity with any NCSI sub-domain.
Nor the ACQ or domains of the AQLQ did show concep-
tual similarity with the NCSI sub-domains fatigue, behav-
ioural impairment, general QoL, health-related QoL, and
satisfaction with relations. The NCSI, ACQ, and AQOLQ were
not significantly related to FEV1, FeNO, BMI.
Discussion
The present study shows that the Nijmegen Clinical
Screening Instrument (NCSI) measures more aspects of
health status than the Asthma Control Questionnaire (ACQ)
and the Asthma Quality of Life Questionnaire (AQLQ-S) in
patients with severe asthma. All sub-domains of the NCSI
proved to be relevant in this patient group.
The main aim of this study was to evaluate the added
value of the NCSI to measure aspects of health status above
the frequently used disease specific instruments AQLQ and
ACQ. The AQLQ and the ACQ are used in numerous studies
to evaluate interventions [24e27], and to describe groups
of patients with asthma [28]. These studies have provided
important information about the experienced symptoms,
activity limitations, emotional functioning, and impact ofTable 3 Correlations between the subscales of the Asthma Cont
Life Questionnaire (AQLQ).
ACQ total AQLQ
Symptoms
ACQ Total 1.00
AQLQ Symptoms 0.83 1.00
AQLQ Activity limitations 0.67 0.85
AQLQ Emotional stimuli 0.35 0.54
AQLQ Environmental stimuli 0.35 0.48
AQLQ Total L0.74 0.90
Note. N Z 167. Correlations >0.70 in bold.environmental stimuli on these patients. However, health
status most certainly comprises of more sub-domains than
the four subscales covered by the AQLQ and the one sub-
scale of the ACQ. We expected that the ten sub-domains of
the NCSI probably measure the same, but certainly even
more, aspects of health status than the AQLQ.
Both the AQLQ and the NCSI measure the subjective
symptoms, subjective impairment, and emotions. However,
the NCSI measures also airflow, body composition and items
that measure the experienced fatigue, satisfaction with life
in general, mood, satisfaction with relationships and
future, and sickness-related behavioural impairment that
are not covered by the AQLQ and ACQ. On all eight NCSI
sub-domains, measured by the questionnaire part, high
proportions of patients with serious problems were found.
In addition, all eight sub-domains were shown to represent
conceptually distinct aspects of the patients health status,
as evidenced by the low intercorrelations. Only the sub-
domains subjective symptoms and subjective impairment
showed conceptual similarity. The domain AQLQ activity
limitation showed high inter correlations with the domains
symptoms and environmental stimuli indicating that they
measure similar concepts. However, the moderate corre-
lation between symptoms and environmental stimuli indi-
cate that these two domains measure separate concepts,
thus both share different parts with the domain activity
limitation. This is not surprising since the items of activity
limitation measure activity limitation due to environmental
stimuli and due to their asthma symptoms. Thus, the NCSI
questionnaire part measures seven aspects of health status
whereas the AQLQ measures three distinct aspects of
health status. This suggests that, in patients with severe
asthma, the NCSI is capable of providing a more complete
picture of the patient’s problems and needs on health
status as compared to the ACQ and AQLQ.
The present study shows that all NCSI subscales repre-
sent highly relevant sub-domains of health status in pa-
tients with severe asthma. In addition, heterogeneity was
found between patients with respect to the number of sub-
domains and in the combination of sub-domains on which
patients experienced severe problems. Low to absent cor-
relations were not only found between the non-
physiological sub-domains of the NCSI, but also between
physiological functioning and symptoms, behavioural
impairment, and QoL. This is not a new phenomena, Haldarrol Questionnaire (ACQ) and domains of the Asthma Quality of
AQLQ
Activity
limitation
AQLQ
Emotional
function
AQLQ
Environmental
stimuli
AQLQ total
1.00
0.39 1.00
0.69 0.34 1.00
0.91 0.64 0.73 1.00
Table 4 Correlations between the sub-domains of the Nijmegen Clinical Screening Instrument (NCSI).
NCSI main
domain
Sub-domain Symptoms Functional impairment Quality of Life
Subjective
symptoms
Dyspnoea
emotions
Fatigue Subjective
impairment
Behavioural
impairment#
General
QoL
Health
related QoL
Satisfaction
relations
Physiological
functioning
FEV1% of predicted 0.23 0.13ns 0.04ns 0.19ns 0.19ns 0.05ns 0.07ns 0.14ns
FeNO 0.09ns 0.18ns 0.15ns 0.06ns 0.09ns 0.14ns 0.04ns 0.01ns
BMI 0.23 0.05ns 0.01ns 0.23 0.23ns 0.03ns 0.17ns 0.01ns
Symptoms Subjective symptoms 1.00
Dyspnoea emotions 0.35 1.00
Fatigue 0.37 0.09ns 1.00
Functional
impairment
Subjective impairment 0.71 0.25 0.46 1.00
Behavioural impairment 0.34ns 0.18ns 0.32ns 0.34 1.00
Quality of
Life
General QoL 0.24 0.67 0.20ns 0.23 0.34ns 1.00
Health related QoL 0.47 0.43 0.41 0.54 0.43 0.67 1.00
Satisfaction relations 0.17ns 0.29 0.09ns 0.20ns 0.26ns 0.52 0.45 1.00
Note. N Z 167 except for behavioural impairment due to a technical error (N Z 53).
284 J.B. Peters et al.et al. [29] also found that symptom perception is not always
in concordance with eosinophilic airway inflammation, and
concluded that both, symptoms and physiologic parame-
ters, have to be measured to get a complete picture.
Several limitations of the present study should be kept in
mind with respect to the generalizability of the results. In
this study we included a select group of patients, more
specifically patients with severe asthma referred to a high-
altitude inpatient pulmonary clinic. Even in this highly
selected group of patients with severe asthma, marked
heterogeneity was found. Which makes it feasible that this
might even be more pronounced in a more general sample
of patients with asthma. The moderate internalTable 5 Cronbach’s reliability coefficient (a), score range, mean
the Asthma Control Questionnaire (ACQ), the Asthma Quality of L
Instrument (NCSI) in patients with severe asthma (N Z 167).
Cronbach’s alpha
ACQ total 0.87
AQLQ
Symptoms 0.88
Activity limitation 0.88
Emotional function 0.84
Environmental stimuli 0.77
Total
NCSI-symptoms
Subjective symptoms 0.89
Dyspnoea emotions 0.83
Fatigue 0.82
NCSI-functional impairment
Behavioural impairment 0.79
Subjective impairment 0.89
NCSI-Quality of Life
General QoL 0.54
Health related QoL 0.47
Satisfaction relations 0.62
Note. Pearson correlations between the sub-domains of the NCSI, th
bilitation. N Z 167 except for behavioural impairment due to techni
a Lower scores indicate more problems.consistencies of the sub-domains of QoL are another limi-
tation. In COPD the same problem exist, a possible expla-
nation is that the included subscales measure different
concepts, however further refinement will be necessary.
One might question the adequacy of the cut-off scores for
normal functioning on the sub-domains of the NCSI. Since,
these cut-offs were based on a group of healthy persons
matched by age and sex to a COPD study group [11]. This
could lead to an underestimation of problems in patients
with asthma, because asthma patients are generally
somewhat younger. Morroy et al. [13], found no significant
differences between patients with Q-fever older and pa-
tients with Q-fever younger than 50 years on seven of eight(SD) and 95% confidence interval of the three questionnaires,
ife Questionnaire (AQLQ) and the Nijmegen Clinical Screening
Score range Mean  SD 95% CI
0e6 3.2  1.1 2.9e3.3
1e7a 3.9  1.1 3.7e4.1
1e7a 3.5  1.2 3.3e3.6
1e7a 4.9  1.3 4.7e5.1
1e7a 4.2  1.5 4.0e4.5
1e7a 4.0  1.0 3.8e4.1
2e20 14.1  4.2 13.5e14.8
6e24 12.0  4.0 11.4e12.6
8e56 47.1  8.7 45.8e48.5
0e99.2 26.2  20.5 20.5e31.8
4e28 17.7  5.4 16.9e18.5
1e101.6 28.0  17.8 25.3e30.7
2e10 6.1  1.7 5.8e6.3
2e10 4.1  2.0 3.8e4.4
e ACQ, and the AQLQ for patients with asthma at start of reha-
cal error (N Z 53).
Table 6 Correlations between the sub-domains of the Nijmegen Clinical screening Instrument (NCSI), the Asthma Control
Questionnaire (ACQ), and the Asthma Quality of Life Questionnaire (AQLQ) to examine conceptual similarity.
ACQ total AQLQ
Symptoms
AQLQ
Activity limitation
AQLQ
Emotional function
AQLQ
Environmental stimuli
AQLQ total
Physiological functioning
FEV1% predicted 0.26 0.16ns 0.09ns 0.20ns 0.01ns 0.14ns
FeNO 0.12ns 0.07ns 0.05ns 0.12ns 0.19ns 0.01ns
BMI 0.18ns 0.12ns 0.16ns 0.07ns 0.02ns 0.13ns
NCSI symptoms
Subjective symptoms 0.66 0.67 0.58 0.40 0.29 0.64
Dyspnoea emotions 0.21 0.30 0.16ns 0.69 0.16ns 0.36
Fatigue 0.44 0.47 0.43 0.16ns 0.19ns 0.43
NCSI functional impairment
Behavioural impairment 0.49 0.53 0.59 0.41 0.39 0.60
Subjective impairment 0.77 L0.70 0.65 0.37 0.30 0.68
NCSI Quality of Life
General QoL 0.18ns 0.29 0.21 0.54 0.23 0.36
Health related QoL 0.40 0.46 0.42 0.50 0.24 0.50
Satisfaction relations 0.15ns 0.18ns 0.25 0.31 0.23 0.27
Note. Pearson correlations between the sub-domains of the Nijmegen Clinical screening Instrument (NCSI), the Asthma Control Ques-
tionnaire (ACQ), and the Asthma Quality of Life Questionnaire (AQLQ) for patients with difficult to control asthma at start of rehabil-
itation. N Z 167 except for behavioural impairment due to technical error (N Z 53). Correlations >0.70 in bold.
ns Z not significant P > 0.01. Correlations in ‘bold-italic’ reach conceptual similarity.
Health status in severe asthma 285NCSI sub-domains, patients younger than 50 years had sig-
nificant higher scores on dyspnoea emotions.
The reason for this study was the need for an instrument
that would enable a detailed evaluation of the needs of
patients with severe asthma and that could help to identify
the factors that aggravate, complicate, or influence disease
perception. The NCSI provides a detailed assessment of
health status, and includes normative data, which render
the patient’s scores on each sub-domain clinically mean-
ingful [11]. The powerful mechanism is not the NCSI as in-
strument per se´, but by discussing the PatientProfileChart
with the patient. The PatientProfileChart visualizes on
which sub-domain a patient functions normally and on
which sub-domain a patient experience severe problems.
The PatientProfileChart allows the doctor and other
healthcare providers to quickly identify the factors leading
to disease burden by discussing the results [30]. Moreover,
the discussion with the patient also facilitates shared-
decision making, which has proven to be important in
promoting adherence [31]. Moreover, the complexity of the
balance between health status and the underlying problems
and self-management capacities, may become visible in the
discussion. This information may help in guiding non-
pharmacological treatment since pharmacological treat-
ment alone seems to be insufficient in patients with severe
asthma [31]. In COPD this approach have been implemented
in usual care since several years and has proven its clinical
relevance. The next step would be to implement the NCSI in
treatment of patients with severe asthma, and examine its
sensitivity to change.
Conclusions
The present study showed that the NCSI, ACQ and AQLQ
measure highly relevant aspects of health status in patientswith severe asthma. However, the NCSI measures more
aspects of health status that are not covered by the ACQ
and AQLQ. The NCSI in combination with the Patient-
ProfileChart might help to identify the impact on daily life,
symptoms, QoL, and impairments in the individual patient
with severe asthma.
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